Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

AstraZeneca share price: Here’s my verdict after the Covid-19 vaccine news

| Jabran Khan

Jabran Khan provides his verdict on the AstraZeneca share price amid the recent Covid-19 vaccine breakthrough and recent performance.

Read more »

Investing Articles

Covid-19 vaccine: 1 biotech stock that profits from AstraZeneca’s success

| Zaven Boyrazian, CFA

Another Covid-19 vaccine may soon be available from AstraZeneca. Zaven Boyrazian analyses the results and finds a larger opportunity for…

Read more »

Investing Articles

AstraZeneca share price: 4 reasons I’d buy after its Covid-19 vaccine results

| Manika Premsingh

The AstraZeneca share price is down after it announced its Covid-19 vaccine results, but it’s unlikely to be affected much…

Read more »

Investing Articles

Should I buy AstraZeneca shares on vaccine news?

| Roland Head

AstraZeneca shares are up by 80% in five years. Roland Head's been taking a look at the pharma stock as…

Read more »

Live: Coronavirus Market Crash Coverage

Stock market rally: 2 dirt-cheap UK shares I’d buy today and hold forever

| Royston Wild

I reckon these exciting UK shares could help me get extremely rich with my Stocks and Shares ISA. I think…

Read more »

Investing Articles

The AstraZeneca share price nears its all-time high! Here’s what I’d do now

| Zaven Boyrazian, CFA

Zaven Boyrazian breaks down the latest results from AstraZeneca to decide whether the share price is justified or pure speculation.

Read more »

Investing Articles

2 stocks I wouldn’t want to own in a stock market crash

| Rachael FitzGerald-Finch

It's good to be prepared for a stock market crash. Here are two shares this Fool is avoiding in her…

Read more »

Investing Articles

Why I’m thinking of AstraZeneca as a great long-term buy

| Jay Yao

Motley Fool contributor Jay Yao writes why he's looking at FTSE 100 component AstraZeneca as a great long-term investment.

Read more »

Investing Articles

3 FTSE 100 stocks I’d buy to play India’s rise

| Jay Yao

Motley Fool contributor Jay Yao writes why he thinks these three FTSE 100 stocks have substantial upside given the development…

Read more »

Investing Articles

Why I’d buy these 2 UK dividend shares in an ISA today to make a passive income

| Peter Stephens

These two UK dividend shares could offer a growing passive income, in my view. Buying them in an ISA today…

Read more »

Investing Articles

Top British stocks for October 2020

| The Motley Fool Staff

We asked our freelance writers to share their top British stocks for October, including AstraZeneca, Pets At Home and Unilever.

Read more »

Investing Articles

Here are 3 safe FTSE 100 dividend hero stocks I’d buy and hold forever

| James J. McCombie

FTSE 100 dividend hero stocks consistently make payouts. Here are three examples that I think are safe bets for income…

Read more »